The effect of high dose inhaled corticosteroids on wheeze in infants after respiratory syncytial virus infection: Randomised double blind placebo controlled trial

BMJ (Online)

Volumn 338, Issue 7701, 2009, Pages 996-

  Ermers, Marieke J J ^a   Rovers, Maroeska M ^b   Van Woensel, Job B ^c   Kimpen, Jan L L ^a   Bont, Louis J ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c EMMA CHILDREN S HOSPITAL   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BECLOMETASONE DIPROPIONATE; BRONCHODILATING AGENT; CORTICOSTEROID; PLACEBO; SALBUTAMOL;

ARTICLE; ARTIFICIAL VENTILATION; CHILD HOSPITALIZATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DECREASED APPETITE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG MEGADOSE; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; HOSPITAL ADMISSION; HUMAN; INFANT; LENGTH OF STAY; LOWER RESPIRATORY TRACT INFECTION; MAJOR CLINICAL STUDY; MALE; METERED DOSE INHALER; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; THRUSH; TREATMENT OUTCOME; VIRAL RESPIRATORY TRACT INFECTION; WHEEZING;

ADMINISTRATION, INHALATION; ADRENAL CORTEX HORMONES; BECLOMETHASONE; CHILD, PRESCHOOL; DOUBLE-BLIND METHOD; FEMALE; HUMANS; HYDROCARBONS, FLUORINATED; INFANT; MALE; METERED DOSE INHALERS; POISSON DISTRIBUTION; QUALITY OF LIFE; RESPIRATORY SOUNDS; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; TREATMENT OUTCOME;

EID: 67649231422     PISSN: None     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.b897     Document Type: Article

References (42)

1. Bont L, Steijn M, van Aalderen WM, Brus F, Th Draaisma JM, Diemen-Steenvoorde RA, et al. Seasonality of long term wheezing following respiratory syncytial virus lower respiratory tract infection. Thorax 2004;59:512-516 (Pubitemid 38797525)
2. Perez-Yarza EG, Moreno A, Lazaro P, Mejias A, Ramilo O. The association between respiratory syncytial virus infection and the development of childhood asthma: a systematic review of the literature. Pediatr Infect Dis J 2007;26:733-739 (Pubitemid 47424645)
3. Stein RT, Sherrill D, Morgan WJ, Holberg CJ, Halonen M, Taussig LM, et al. Respiratory syncytial virus in early life and risk of wheeze and allergy by age 13 years. Lancet 1999;354:541-545 (Pubitemid 29381367)
4. Kuehni CE, Davis A, Brooke AM, Silverman M. Are all wheezing disorders invery young (preschool) children increasing in prevalence? Lancet 2001;357:1821-1825.
5. Bont L, Steijn M, van Aalderen WM, Kimpen JL. Impact of wheezing after respiratory syncytial virus infection on health-related quality of life. Pediatr Infect Dis J 2004;23:414-417 (Pubitemid 38621479)
6. Stevens CA, Turner D, Kuehni CE, Couriel JM, Silverman M. The economic impact of preschool asthma and wheeze. Eur Respir J 2003;21:1000-1006 (Pubitemid 36675617)
7. Agertoft L, Pedersen S. Effect of long-term treatment with inhaled budesonide on adult height in children with asthma. N Engl J Med 200012;343:1064-1069
8. Reijonen T, Korppi M, Kuikka L, Remes K. Anti-inflammatory therapy reduces wheezing after bronchiolitis. Arch Pediatr Adolesc Med 1996;150:512-517 (Pubitemid 26139405)
9. Carlsen KH, Leegaard J, Larsen S, Orstavik I. Nebulised beclomethasone dipropionate in recurrent obstructive episodes after acute bronchiolitis. Arch Dis Child 1988;63:1428-1433 (Pubitemid 19011240)
10. Kajosaari M, Syvanen P, Forars M, Juntunen-Backman K. Inhaled corticosteroids during and after respiratory syncytial virusbronchiolitis may decrease subsequent asthma. Pediatr Allergy Immunol 2000;11:198-202. (Pubitemid 30666562)
11. Chauliac ES, Silverman M, Zwahlen M, Strippoli MP, Brooke AM, Kuehni AC. The therapy of pre-school wheeze: appropriate and fair? Pediatr Pulmonol 2006;41:829-838
12. Kimpen JL, Schaad UB. Treatment of respiratory syncytial virus bronchiolitis: 1995 poll of members of the European Society for Paediatric Infectious Diseases. Pediatr Infect Dis J 1997;16:479-481
13. Plint AC, Johnson DW, Wiebe N, Bulloch B, Pusic M, Joubert G, et al. Practice variation among pediatric emergency departments in the treatment of bronchiolitis. Acad Emerg Med 2004;11:353-360 (Pubitemid 38437010)
14. Cahill P, Finan E, Loftus BG. Management of bronchiolitis: current practices in Ireland. Ir Med J 2002 Jun;95(6):167-169 (Pubitemid 36105226)
15. Barben J, Hammer J. Current management of acute bronchiolitis in Switzerland. Swiss Med Wkly 2003;133:9-15. (Pubitemid 36152219)
16. Blom D, Ermers M, Bont L, van Aalderen WM, van Woensel JB. Inhaled corticosteroids during acute bronchiolitis in the prevention of postbronchiolitic wheezing. Cochrane Database Syst Rev 2007;(1):CD004881. (Pubitemid 351820477)
17. Janssens HM, de Jongste JC, Hop WC, Tiddens HA. Extra-fine particles improve lung delivery of inhaled steroids in infants: a study in an upper airway model. Chest 2003;123:2083-2088 (Pubitemid 36706736)
18. Kamps AW, van Ewijk B, Roorda RJ, Brand PL. Poor inhalation technique, evenafter inhalation instructions, in childrenwithasthma. Pediatr Pulmonol 2000;29:39-42. (Pubitemid 30036675)
19. Bont L, Heijnen CJ, Kavelaars A, van Aalderen WMC, Brus F, Draaisma JT, et al. Monocyte IL-10 production during respiratory syncytial virus bronchiolitis is associated with recurrentwheezing in a one-year follow-up study. Am J Respir Crit Care Med 2000;161:1518-1523 (Pubitemid 30329021)
20. Bunge EM, Essink-Bot ML, Kobussen MP, Suijlekom-Smit LW, Moll HA, Raat H. Reliability and validity of health statusmeasurement by the TAPQOL. Arch Dis Child 2005;90:351-358
21. Arets HG, Brackel HJ, van der Ent CK. Applicability of interrupter resistancemeasurements using theMicroRint indaily practice. Respir Med 2003;97:366-374 (Pubitemid 36410604)
22. Burney PG, Luczynska C, Chinn S, Jarvis D. The European Community Respiratory Health Survey. Eur Respir J 1994;7:954-960 (Pubitemid 24153598)
23. Rijcken B. Het Europees luchtwegonderzoek Nederland. Tijdschr Soc Gezondheidsz 1992;(70):259-260
24. Bont L, van Aalderen WM, Versteegh J, Brus F, Draaisma JT, Pekelharing-Berghuis M, et al. Airflow limitation during respiratory syncytial virus lower respiratory tract infection predicts recurrent wheezing. Pediatr Infect Dis J 2001;20:277-282 (Pubitemid 32240267)
25. Greenland S, Finkle WD. A critical look at methods for handling missing covariates in epidemiologic regression analyses. Am J Epidemiol 1995;142:1255-1264 (Pubitemid 26006424)
26. Harrell FE Jr, Lee KL, Mark DB.Multivariable prognosticmodels: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med 1996;15:361-387 (Pubitemid 26072233)
27. Ermers MJ, Hoebee B, Hodemaekers HM, Kimman TG, Kimpen JL, Bont L. IL-13 genetic polymorphism identifies children with late wheezing after respiratory syncytial virus infection. J Allergy Clin Immunol 2007;119:1086-1091 (Pubitemid 46654163)
28. Bisgaard H. A randomized trial ofmontelukast in respiratory syncytial virus postbronchiolitis. Am J Respir Crit Care Med 2003;167:379-383 (Pubitemid 36216419)
29. Bisgaard H, Flores-Nunez A, Goh A, Azimi P, Halkas A, Malice MP, et al. Study of montelukast for the treatment of respiratory symptoms of post-RSV-bronchiolitis in children. Am J Respir Crit Care Med 2008;178:854-860
30. Behrendt CE, Decker MD, Burch DJ, Watson PH. International variation in the management of infants hospitalized with respiratory syncytial virus. International RSV Study Group. Eur J Pediatr 1998;157:215-220 (Pubitemid 28113875)
31. Christakis DA, Cowan CA, Garrison MM, Molteni R, Marcuse E, Zerr DM. Variation in inpatient diagnostic testing and management of bronchiolitis. Pediatrics 2005;115:878-884
32. Corneli HM, Zorc JJ, Majahan P, Shaw KN, Holubkov R, Reeves SD, et al. A multicenter, randomized, controlled trial of dexamethasone for bronchiolitis. N Engl J Med 2007;357:331-339 (Pubitemid 47124133)
33. De Boeck K, Van der Aa N, Van Lierde S, Corbeel L, Eeckels R. Respiratory syncytial virus bronchiolitis: a double-blind dexamethasone efficacy study. J Pediatr 1997;131:919-921 (Pubitemid 28027621)
34. Bulow SM, Nir M, Levin E, Friis B, Thomsen LL, Nielsen JE, et al. Prednisolone treatment of respiratory syncytial virus infection: a randomized controlled trial of 147 infants. Pediatrics 1999;104:e77.
35. Roosevelt G, Sheehan K, Grupp-Phelan J, Tanz RR, Listernick R. Dexamethasone in bronchiolitis: a randomised controlled trial. Lancet 1996;348:292-295 (Pubitemid 26254628)
36. Bisgaard H, Hermansen MN, Loland L, Halkjaer LB, Buchvald F. Intermittent inhaled corticosteroids in infants with episodic wheezing.N Engl J Med 2006;354:1998-2005.
37. Guilbert TW, Morgan WJ, Zeiger RS, Mauger DT, Boehmer SJ, Szefler SJ, et al. Long-term inhaled corticosteroids in preschool children at high risk for asthma. N Engl J Med 2006;354:1985-1997
38. Bont L, Kimpen JL, Ermers MJ. Inhaled corticosteroids and children. N Engl J Med 2006;355:624-625 (Pubitemid 44200659)
39. McKean M, Ducharme F. Inhaled steroids for episodic viral wheeze of childhood. Cochrane Database Syst Rev 2000;(2):CD001107.
40. Richter H, Seddon P. Early nebulized budesonide in the treatment of bronchiolitis and the prevention of postbronchiolitic wheezing. J Pediatr 1998;132:849-853 (Pubitemid 28232939)
41. Fox GF, Everard ML, Marsh MJ, Milner AD. Randomised controlled trial of budesonide for the prevention of post-bronchiolitiswheezing. Arch Dis Child 1999;80:343-347 (Pubitemid 29164758)
42. Lehtinen P, Ruohola A, Vanto T, Vuorinen T, Ruuskanen O, Jartti T. Prednisolone reduces recurrent wheezing after a first wheezing episode associated with rhinovirus infection or eczema. J Allergy Clin Immunol 2007;119:570-575 (Pubitemid 46320577)